OLR1 and pneumonia: In the subgroups formed according to disease severity, LOX-1 levels in patients with severe pneumonia were found to be statistically significantly higher than both uncomplicated COVID-19 patients (p < 0.01) and mild–moderate pneumonia patients (p < 0.05).